Optimizing the Diagnosis of Tuberculous Pericarditis through the Use of GeneXpert MTB/RIF

Authors

  • Kholoud Maafi Hassan II University of Casablanca, Laboratory of Biotechnology, Agri-Food, Materials and Environment, Faculty of Science and Technology Mohammedia, BP 146, Mohammedia 20650, Morocco (ROR: https://ror.org/001q4kn48); Ibn Sina University Hospital in Rabat, Rabat, Morocco (ROR: https://ror.org/038zpvz53); Faculty of Medicine and Pharmacy of Rabat, Mohamed V University, Rabat, Morocco (ROR: https://ror.org/00r8w8f84).
  • Hamza Abidar Ibn Sina University Hospital in Rabat (ROR: https://ror.org/038zpvz53), Rabat, Morocco; Faculty of Medicine and Pharmacy of Rabat, Mohamed V University (ROR: https://ror.org/00r8w8f84), Rabat, Morocco.
  • Karim Souly Ibn Sina University Hospital in Rabat (ROR: https://ror.org/038zpvz53), Rabat, Morocco; Faculty of Medicine and Pharmacy of Rabat, Mohamed V University (ROR: https://ror.org/00r8w8f84), Rabat, Morocco.
  • Souad Aboudkhil Hassan II University of Casablanca, Laboratory of Biotechnology, Agri-Food, Materials and Environment, Faculty of Science and Technology Mohammedia, BP 146, Mohammedia 20650, Morocco (ROR: https://ror.org/001q4kn48).

DOI:

https://doi.org/10.63095/NBSEH.26.695425

Keywords:

Pericardial Tuberculosis, GeneXpert MTB/RIF, Molecular Diagnosis

Abstract

This study evaluated the performance of the GeneXpert MTB/RIF® test (Cepheid Inc., USA) for detecting Mycobacterium tuberculosis and Rifampicin resistance in pericardial tuberculosis (TBP), compared to culture, the reference method recommended by the Moroccan National Tuberculosis Control Programme (PNLAT). Conducted prospectively over 36 months, the study analysed 27 pericardial fluid samples from suspected TBP cases at Ibn Sina University Hospital, Rabat. Conventional methods (bacilloscopy and culture) were compared to GeneXpert MTB/RIF. Microscopy showed no positive results, whereas GeneXpert MTB/RIF and culture yielded positivity rates of 14.81% and 11.11%, respectively. Most culture-positive samples were bacilloscopy-negative. The GeneXpert MTB/RIF assay showed 100% sensitivity and NPV, with 95.8% specificity and 75% PPV. No Rifampicin resistance was identified. The findings suggest that GeneXpert MTB/RIF is a rapid and reliable first-line diagnostic tool for pericardial tuberculosis and may replace smear microscopy and culture, which require prolonged incubation.

Downloads

Download data is not yet available.

References

World Health Organization, 2020, Global tuberculosis report 2020. World Health Organization (October, 2020). https://www.who.int/publications/i/item/9789240013131

Ronacher, K. A., Joosten, S., Van Crevel, R., Dockrell, H. M., Walzl, G. H. M., & Ottenhoff, T., 2015, Acquired immunodeficiencies and tuberculosis: focus on HIV/AIDS and diabetes mellitus. Immunological Reviews 264(1),121–37. https://doi.org/10.1111/imr.12257

Ntsekhe, M., Mayosi, M. B., 2013, Tuberculous pericarditis with and without HIV. Heart Failure Reviews 18(3), 367-73. https://pubmed.ncbi.nlm.nih.gov/22427006/

Howlett, P., Bruyn, E. D., Morrison, H., Godsent, I. C., Wilkinson, K. A., Ntsekhe, M., & Wilkinson, R. J., 2020, The immunopathogenesis of tuberculous pericarditis. Microbes and Infection 22(2020), 172-181. https://doi.org/10.1016/j.micinf.2020.02.001

Damasceno, A., Mayosi, B. M., Sani, M., Ogah, O. S., Mondo, C., Ojji, D., Dzudie, A., Kouam, C. K., Suliman, A., Schrueder, N., Yonga, G., Ba, S. A., Maru, F., Alemayehu, B., Edwards, C., Davison, B. A., Cotter, G., & Sliwa, K., 2012, The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the sub-Saharan Africa survey of heart failure. Archives of Internal Medicine 172(18),1386-1394. https://pubmed.ncbi.nlm.nih.gov/22945249/

Giliomee, L. J., Doubell, A. F., Robbertse, P. S., John, T. J., & Herbst, P. G., 2024, Novel role of cardiovascular MRI to contextualise tuberculous pericardial inflammation and oedema as predictors of constrictive pericarditis. Frontiers in Cardiovascular Medicine 11,1329767. https://pubmed.ncbi.nlm.nih.gov/38562190/

Isiguzo, G., Bruyn, E. D., Howlett, P., & Ntsekhe, M., 2020, Diagnosis and Management of Tuberculous Pericarditis: What Is New?. Current Cardiology Reports 22(1),2. https://doi.org/10.1007/s11886-020-1254-1

Liu, C., Cui, Y.-L., Ding, C.-M., Wu, Y.-H., Li, H.-L., Liu, X.-F., & Hu, Z.-D., 2018, Diagnostic accuracy of interferon-gamma in pericardial effusions for tuberculous pericarditis: a meta-analysis. Journal of Thoracic Disease 10(2),854-860. https://pubmed.ncbi.nlm.nih.gov/29607157/

Naicker, K., & Ntsekhe, M., 2020, Tuberculous pericardial disease: a focused update on diagnosis, therapy and prevention of complications. Cardiovascular Diagnosis and Therapy 10(2),289–295. https://doi.org/10.21037/cdt.2019.09.20

Pervez, A., Umar Hasan, S., Hamza, M., Asghar, S., Qaiser, M. H., Zaidi, S., & Mustansar, I., 2024, Diagnostic accuracy of tests for tuberculous pericarditis: A network meta-analysis. Indian Journal of Tuberculosis 71(2),185-194. https://doi.org/10.1016/j.ijtb.2023.05.013

Holtz, T. H., Kabera, G., Mthiyane, T., Zingoni, T., Nadesan, S., Ross, D., Allen, J., Chideya, S., Sunpath, H., & Rustomjee, R., 2011, Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. The Lancet Infectious Diseases 11(7), 533–540. https://doi.org/10.1016/S1473-3099(11)70057-3

Dybowska, M., Błasińska, K., Gątarek, J., Klatt, M., Augustynowicz-Kopeć, E., Tomkowski, W., & Szturmowicz, M., 2022, Tuberculous Pericarditis - Own Experiences and Recent Recommendations. European Heart Journal – Diagnostics and Imaging 12(3), 619. https://doi.org/10.3390/diagnostics12030619

Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R., 2018, Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance. Cochrane Database of Systematic Reviews 8(8), CD012768. https://pubmed.ncbi.nlm.nih.gov/30148542/

Lombardi, G., Di Gregori, V., Girometti, N., Tadolini, M., Bisognin, F., & Monte, P. D., 2017, Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF. PLOS ONE 12(4), e0176186. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0176186

Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R., 2014, Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. European Respiratory Journal 44(2),435–446. https://pubmed.ncbi.nlm.nih.gov/24696113/

Saeed, M., Ahmad, M., Iram, S., Riaz, S., Akhtar, M., & Aslam, M., 2017, GeneXpert technology: a breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Medical Journal 38(7), 699-705. https://doi.org/10.15537/smj.2017.7.17694

Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., Milovic, A., Jones, M., O’Brien, S. M., Persing, D. H., Ruesch-Gerdes, S., Gotuzzo, E., Rodrigues, C., Alland, D., & Perkins, M. D., 2010, Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine 363(11), 1005-1015. https://doi.org/10.1056/nejmoa0907847

World Health Organization, 2014, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system for the diagnosis of pulmonary and extrapulmonary tuberculosis in adults and children. https://www.who.int/publications/i/item/9789241506335

Matabane, M. M. Z., Ismail, F., Strydom, K. A., Onwuegbuna, O., Omar, S. V., & Ismail, N., 2015, Evaluation of three commercial molecular tests for the detection of Mycobacterium tuberculosis from clinical samples in a high TB-HIV burden setting. BMC Infectious Diseases 15(1), 508. https://doi.org/10.1186/s1287

World Health Organization, 2011, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system: policy statement. World Health Organization. https://www.who.int/publications/i/item/9789241501545

Yu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y., 2019, Diagnostic accuracy of the Xpert MTB/RIF assay for lymph node tuberculosis: a systematic review and meta-analysis. BioMed Research International, 4878240. https://doi.org/10.1155/2019/4878240

World Health Organization, 2022, WHO consolidated guidelines on tuberculosis: module 3: diagnosis: tests for TB infection. World Health Organization. https://www.who.int/publications/i/item/9789240056084

World Health Organization, 2024, WHO consolidated guidelines on tuberculosis: module 3: diagnosis: rapid diagnostics for tuberculosis detection, 3rd ed. World Health Organization. https://www.who.int/publications/i/item/9789240089488

Piatek, A. S., Telenti, A., Murray, M. R., El-Hajj, H., Jacobs, W. R., Kramer, F. R., & Alland, D., 2000, Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrobial Agents and Chemotherapy 44(1), 103-110. https://doi.org/10.1128/aac.44.1.103-110.2000

Tahseen, S., Qadeer, E., Khanzada, F. M., Rizvi, A. H., Dean, A., Van Deun, A., & Zignol, M., 2016, Use of Xpert® MTB/RIF assay in the first national anti-tuberculosis drug resistance survey in Pakistan. The International Journal of Tuberculosis and Lung Disease 20(4), 448-455. https://doi.org/10.5588/ijtld.15.0645

Centers for Disease Control and Prevention (CDC), 2023, Tuberculosis (TB): Tuberculosis Laboratories. https://www.cdc.gov/tb/php/laboratory-information/?CDC_AAref_Val=https://www.cdc.gov/tb/topic/laboratory/default.htm

Tian, P., Shen, Y., Wang, Y., Chun, C., Feng, M., Zhu, J., Yang, T., Chen, L., & Wang, F., 2015, Diagnostic value of nucleic acid amplification tests on bronchoalveolar lavage fluid for smear-negative pulmonary tuberculosis: a meta-analysis. BioScience Reports 35(4), e00232. https://pmc.ncbi.nlm.nih.gov/articles/PMC4613677/

Shen, Y., Yu, G., Zhong, F., & Kong, X., 2019, Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosis: a meta-analysis. PLOS ONE 14(8), e0221427. https://doi.org/10.1371/journal.pone.0221427

Shen, Y., Yu, G., Zhao, W., & Lang, Y., 2021, Efficacy of Xpert MTB/RIF Ultra in diagnosing tuberculosis meningitis. Medicine 100(29), e26778. https://doi.org/10.1097/md.0000000000026778

Ministry of Health and Social Protection of Morocco, 2024, National guidelines for the diagnosis and management of extrapulmonary tuberculosis (EPTB). https://www.sante.gov.ma/Documents/2024/04/Version%20Finale%20Lignes%20Directrices%20TEP%20PNLAT%20Version%20finale%20%20Août%202023.pdf

Diallo, K., Diatta, A., Wembulua, B. S., Camara, A., Sarr, H., Coly, M. N., Diatta, A., & Manga, N. M., 2022, Performance of GeneXpert in the diagnosis of tuberculosis in a decentralized area: Example of Hopital De La Paix, in Ziguinchor, Southern Senegal from 2016 to 2018. International Journal of Tropical Diseases 5(1), Article 059. https://doi.org/10.23937/2643-461X/1710059

Toure, N. O., Thiam, K., Wayzani, M., Dia Kane, Y., Mbaye, F. B. R., Cissé, M. F., & Diatta, A., 2017, Use of GeneXpert in the diagnosis of extrapulmonary tuberculosis at CHNU de Fann, Dakar. Revue des Maladies Respiratoires 34, A214. https://www.em-consulte.com/article/1101209/utilisation-du-genexpert-dans-le-diagnostic-de-la-

Pandie, S., Peter, J. G., Kerbelker, Z. S., Meldau, R., Theron, G., Govender, U., Ntsekhe, M., Dheda, K., & Mayosi, B. M., 2014, Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-gamma in a high burden setting: a prospective study. BMC Medicine 12(1), 101. https://doi.org/10.1186/1741-7015-12-101

Yu, G., Ye, B., Chen, D., Zhong, F., Chen, G., Yang, J., Xu, L., & Xu, X., 2017, Comparison between the diagnostic validities of Xpert MTB/RIF and interferon-gamma release assays for tuberculous pericarditis using pericardial tissue. PLOS ONE 12(12), e0188704. https://doi.org/10.1371/journal.pone.0188704

Hu, X., Xing, B., Wang, W., Yang, P., Sun, Y., Zheng, X., Shang, Y., Chen, F., Liu, N., Yang, L., Zhao, Y., Tan, J., Zhang, X., Wang, Y., Zhang, Z., & Liu, Y., 2020, Diagnostic values of Xpert MTB/RIF, T-SPOT.TB and adenosine deaminase for HIV-negative tuberculous pericarditis in a high burden setting: a prospective observational study. Scientific Reports 10(1), 16325. https://doi.org/10.1038/s41598-020-73220-y

Saeed, M., Ahmad, M., Iram, S., Riaz, S., Akhtar, M., & Aslam, M., 2017, GeneXpert technology: a breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than two hours. Saudi Medical Journal 38(7), 699-705. https://doi.org/10.15537/smj.2017.7.17694

Sharma, S. K., Kohli, M., Chaubey, J., Yadav, R. N., Sharma, R., Singh, B. K., Sreenivas, V., Sharma, A., Bhatia, R., Jain, D., Seenu, V., Dhar, A., & Soneja, M., 2014, Evaluation of Xpert MTB/RIF assay performance in diagnosing extrapulmonary tuberculosis among adults in a tertiary care centre in India. European Respiratory Journal 44(4), 1090-1093. https://doi.org/10.1183/09031936.00059014

Khan, A. S., Ali, S., Khan, M. T., Ahmed, S., Khattak, Y., Abduljabbar, Irfan, M., & Sajjad, W., 2018, Comparison of GeneXpert MTB/RIF assay and LED-FM microscopy for the diagnosis of extra pulmonary tuberculosis in Khyber Pakhtunkhwa, Pakistan. Brazilian Journal of Microbiology 49(4), 909–913. https://doi.org/10.1016/j.bjm.2018.02.011

Allahyartorkaman, M., Mirsaeidi, M., Hamzehloo, G., Amini, S., Zakiloo, M., & Javad Nasiri, M., 2019, Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: a multicenter surveillance study. Scientific Reports 9(1), 18515. https://www.semanticscholar.org/paper/Low-diagnostic-accuracy-of-Xpert-MTB-RIF-assay-for-Allahyartorkaman-Mirsaeidi/343dfb3d1abbdf145fe8f5dfcaa799fec607d12f

Theron, G., Peter, J., Calligaro, G., Meldau, R., Hanrahan, C., Khalfey, H., Matinyenya, B., Muchinga, T., Smith, L., Pandie, S., Lenders, L., Patel, V., Mayosi, B. M., & Dheda, K., 2014, Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments. Scientific Reports 4, 5658. https://www.nature.com/articles/srep05658

Ullah, I., Javaid, A., Masud, H., Ali, M., Basit, A., Ahmad, W., Younis, F., Yasmin, R., Khan, A., Jabbar, A., Husain, M., & Butt, Z. A., 2017, Rapid detection of Mycobacterium tuberculosis and rifampicin resistance in extrapulmonary tuberculosis and sputum smear-negative pulmonary suspects using Xpert MTB/RIF. Journal of Medical Microbiology 66(4), 412-418. https://doi.org/10.1099/jmm.0.000449

Yu, G., Wang, L., Shen, Y., Fang, L., Yang, J., Ye, B., Xu, K., & Zhong, F., 2022, Comparison of the diagnostic accuracy of Xpert MTB/RIF and CapitalBio Mycobacterium RT-PCR detection assay for tuberculous pericarditis. Infection and Drug Resistance 15, 2127-2135. https://doi.org/10.2147/idr.s360064

Mahmood, H., Zaib, T., & Maken, Z. H., 2018, GENEXPERT® technology: A breakthrough for diagnosis of tuberculous pericarditis and pleuritis in less than two hours. Journal of University Medical & Dental College 9(3), 22–30. https://www.jumdc.com/index.php/jumdc/article/view/86

Gopalaswamy, R., Azger Dusthackeer, V. N., Kannayan, S., & Subbian, S., 2021, Extrapulmonary tuberculosis: an update on diagnosis, treatment and drug resistance. Journal of Respiration 1, 141–164. https://doi.org/10.3390/jor1020015

Yu, G., Shen, Y., Ye, B., Chen, D., & Xu, K., 2020, Comparison of CapitalBio™ Mycobacterium nucleic acid detection test and Xpert MTB/RIF assay for rapid diagnosis of extrapulmonary tuberculosis. Journal of Microbiological Methods 168, 105780. https://doi.org/10.1016/j.mimet.2019.105780

Yu, G., Zhong, F., Shen, Y., & Zheng, H., 2021, Diagnostic accuracy of the Xpert MTB/RIF assay for tuberculous pericarditis: a systematic review and meta-analysis. PLOS ONE 16(9), e0257220. https://doi.org/10.1371/journal.0257220

Seck, M., 2023, Diagnosis and therapeutic attitudes in tuberculous pericarditis. Medical Doctorate Thesis, N°215, Mohammed V University, Rabat, Morocco. https://toubkal.imist.ma/bitstream/handle/123456789/30795/M2152023.pdf?sequence=1

Chahboune, M., Barkaoui, M., Iderdar, Y., Alwachami, N., Mourajid, Y., Ifleh, M., Boumendil, K., Bachar, K., & Madani, S. E., 2022, Profil épidémiologique, aspects diagnostiques et évolutifs des patients tuberculeux au centre de diagnostic de la tuberculose et des maladies respiratoires de Settat, Maroc. Pan African Medical Journal 42, 185. https://doi.org/10.11604/pamj.2022.42.185.35250

World Health Organization, 2023, Global tuberculosis report 2023. World Health Organization. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2023

Ministry of Health and Social Protection of Morocco, 2024, National guidelines for the management of TB/HIV co-infection (for health professionals). https://www.sante.gov.ma/Documents/2024/04/Guide%20national%20de%20p.e.c%20de%20la%20co-infection%20TB%20-VIH%20VF.pdf

World Health Organization, 2018, Global tuberculosis report 2018. World Health Organization. https://www.who.int/publications/i/item/9789241565646

World Health Organization, 2011, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. https://www.who.int/publications/i/item/9789241501545

World Health Organization, 2016, Global strategy and targets for tuberculosis prevention, care and control after 2015. https://apps.who.int/gb/ebwha/pdf_files/WHA67/A67_R1-en.pdf

This prospective study evaluated the GeneXpert MTB/RIF® test (Cepheid Inc., USA) for diagnosing pericardial tuberculosis (TBP) in comparison with culture, the reference method recommended by the Moroccan National Tuberculosis Control Program (PNLAT). Twenty-seven pericardial fluid samples collected over 36 months at Ibn Sina University Hospital, Rabat, were analysed using bacilloscopy, culture, and GeneXpert MTB/RIF. Microscopy showed no positive results, whereas GeneXpert MTB/RIF and culture yielded positivity rates of 14.81% and 11.11%, respectively; the assay also demonstrated 100% sensitivity and NPV, with 95.8% specificity and 75% PPV. These findings indicate that GeneXpert MTB/RIF is a rapid and reliable first-line diagnostic tool for pericardial tuberculosis, providing results much faster than culture.

Downloads

Additional Files

Published

2026-06-07

How to Cite

Maafi, K., Abidar, H., Souly, K., & Aboudkhil, S. (2026). Optimizing the Diagnosis of Tuberculous Pericarditis through the Use of GeneXpert MTB/RIF. Natural Built Social Environment Health, 2(3), 141–153. https://doi.org/10.63095/NBSEH.26.695425